Compare Simon Property Group Inc (SPG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Simon Property Group Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Simon Property Group Inc trades at $227 (market cap $74.00B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Simon Property Group Inc pays a 3.86% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| SPG | XBI | |
|---|---|---|
Market Cap | $74.00B | — |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $228.70 | $164.28 |
52-Week Low | $160.68 | $85.16 |
Enterprise Value | $102.48B | — |
Dividend Yield | 3.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
